Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes we disagree, the YTD action speaks more volume "with relations to Leo's comments" on not doing a RS. The rally last-week did not start at 2.50 like you suggest (2.64) and never reached 3.75. 3.65 was the inter-day high on 7/20. Again, what does Leo do if the PPS doesn't rise on news so he can up-list? That's the big decision he'll have to address. Staying on the pinks forever is not an option and Leo knows it...
http://finance.yahoo.com/q/hp?s=CTIX+Historical+Prices
Winnail, read my post again, since the beginning of the year... How many press releases has Leo issued in 2015, while the PPS is down 35 percent YTD. The point is, the CEO made a statement that he won't do a RS and let news take the PPS higher. So far, that strategy has not worked. Also, the PPS is down since the B news last-week, which most here thought would rally and hold.
Who said 3 weeks ago, my point was YTD performance... Closed 12/31/14 at 4.39.
Also, a 35 percent drop YTD, with little dilution. So the CEO has to ask himself, how do I leave the pink sheets to get more exposure? The big money will not invest here until they up-list or form a partnership. Leo ruled out both earlier hoping for a PPS rise on news.
3.01 sound the trumpets Leo... The great news has not moved the stock, time to get off the pinks... RS or partnership your only 2 routes.
CTIX closed 4.39 on 12/31/14... With all the great news since, the stock has dropped 35 percent with not much dilution. So Leo's theory of waiting for a higher PPS, "so they can up-list" has proved to be wrong. The biggest problem is trading on the pinks... Not the science, not dilution...
This company is too predictable with it's news... Now we're waiting for a corporate update with the start of P... Partnership should be the focus since up-listing has failed. If Leo doesn't want to do a RS, then there has to be another solution than getting eaten alive on-the-pinks. Just my opinion....
Detailed Nasdaq Q & A For Up-listing.
https://listingcenter.nasdaq.com/Material_Search.aspx?cid=34&mcd=LQ
How do we know they don't have to reapply? After a period of time, wouldn't the Nasdaq want to review all the requirements? It is almost 6 months since Leo applied... Maybe, that's the delay?
Citrati, If that's your opinion then don't read my posts. The big qualifying issue back in February was not the PPS, it was the BOD's not in place. When the BODs came on board in April the PPS was below standard. Again, Leo messed the up-listing up... What's holding the PPS back is the market they trade on...
Going back to when Leo applied, the BOD's were yet in place. Probably nullified any PPS above standard requirement.
Thanks Loanranger for finding my post. Every time AlanC posts those bogus stats, we'll counter with my post... GLTY
AlanC, Bogus stat... These statistics are also unverified... Below is a great explanation. Also, check out Facebook's so-called short stats that are not legit... You will notice the same type graph...
http://shortvolume.com/ Enter FB for Facebook
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=57101068
An explanation of Finra's daily short volume.
(Courtesy of a post made by pantherj)
The daily short interest report from FINRA is as widely misinterpreted as any report ever put out. Yet, once a few basics are understood, it becomes very logical. The huge short volume seen in the daily reports are almost instantaneously covered; within a few milliseconds or a few hours at worst. The best explanation of this report, that I've ever seen, was posted by "Dave Patch" of "Investigatethesec.com."
Posted by: patchman Date: Wednesday, March 03, 2010 6:31:31 PM
In reply to: fourkids_9pets who wrote msg# 648 Post # of 951
Short Sale Volume Reporting’s are deceiving.
I spoke to FINRA today and found out some very interesting things that until now I did not fully understand. I knew there was something wrong with this transparency of information but was not 100% sure what it was. I think I have my answer and it was enlightening.
I was first directed to the Notice to Members memo dated 9/29/2009
www.finra.org/Industry/Regulation/Notices/2009/P120045
The individual I spoke with wanted to make clear that to maintain proper trade volume reporting accuracy, a trade with multiple legs in the trade would only be reported once in the volume reports. The example given would be.
Investor A is long 100 shares and wants to sell. They enter the order through their broker that is routed to a market maker. That market maker will go out and sell the stock into the market before they have bought the stock from you/your broker to close out their account. They do not take possession first as there is no guarantee they can sell the order into the market. By this Notice, the actual sale INTO the market is a short sale because the market maker sold the stock into the market BEFORE they had purchased the stock from you. It is a technicality since they know there position will be closed out minutes later when they go in and buy your shares. To avoid doubling up on trade volume and distorting the picture, only the sale into the market (consolidated tape) is recorded and not the second leg which was the sale transaction between seller and market maker.
So, this is why the short sale volume is high but also why the FTD’s and bi-Monthly short interest reports are not showing any indications of this volume. The short isn’t really a short it is the execution of a long sale by a market maker. The key language in the FINRA notice is this:
Quote:
--------------------------------------------------------------------------------
The Daily Short Sale Volume File will provide daily access to the aggregate volume of short sales in NMS Stocks and OTC Equity Securities reported to a consolidated tape and traded over-the-counter during regular trading hours on each trading day.
75K shares drops the price 7 percent... And some believe an up-listing is not needed? Cant blame the shorts on this drop... no buying interest.
Interesting InVivo Therapeutics PRs from 3/24 and 4/16. They did a RS on 4/8, Nasdaq Approval on 4/16 and traded 4/17. So if the 3 dollar PPS is CTIX's standard, then they should be up-listing later this week or early next? Again, Leo mentioned PPS as the reason for not up-listing. Also, Invivo's stock is up 40 percent since the RS on 4/8. 11.60 to 16.69 current... An example where a RS has worked. Stock is up over 200 percent YTD...
https://finance.yahoo.com/news/invivo-therapeutics-announces-reverse-stock-120000176.html
https://finance.yahoo.com/news/invivo-therapeutics-announces-uplisting-nasdaq-120000359.html
Drano, just an opinion like all of your posts... Drano, the one and only...LOL
Need to get up-listed, the pink-sheets is a playground for market makers and momentum traders. Also, the pinks limit exposure to the real cash from investing. The past 5 minutes, 10K volume drops the PPS by 2 percent? Welcome to the pinks...
AlanC, Bogus stat... These statistics are also unverified... Below is a great explanation. Also, check out Facebook's so-called short stats that are not legit... You will notice the same type graph...
http://shortvolume.com/ Enter FB for Facebook
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=57101068
An explanation of Finra's daily short volume.
(Courtesy of a post made by pantherj)
The daily short interest report from FINRA is as widely misinterpreted as any report ever put out. Yet, once a few basics are understood, it becomes very logical. The huge short volume seen in the daily reports are almost instantaneously covered; within a few milliseconds or a few hours at worst. The best explanation of this report, that I've ever seen, was posted by "Dave Patch" of "Investigatethesec.com."
Posted by: patchman Date: Wednesday, March 03, 2010 6:31:31 PM
In reply to: fourkids_9pets who wrote msg# 648 Post # of 951
Short Sale Volume Reporting’s are deceiving.
I spoke to FINRA today and found out some very interesting things that until now I did not fully understand. I knew there was something wrong with this transparency of information but was not 100% sure what it was. I think I have my answer and it was enlightening.
I was first directed to the Notice to Members memo dated 9/29/2009
www.finra.org/Industry/Regulation/Notices/2009/P120045
The individual I spoke with wanted to make clear that to maintain proper trade volume reporting accuracy, a trade with multiple legs in the trade would only be reported once in the volume reports. The example given would be.
Investor A is long 100 shares and wants to sell. They enter the order through their broker that is routed to a market maker. That market maker will go out and sell the stock into the market before they have bought the stock from you/your broker to close out their account. They do not take possession first as there is no guarantee they can sell the order into the market. By this Notice, the actual sale INTO the market is a short sale because the market maker sold the stock into the market BEFORE they had purchased the stock from you. It is a technicality since they know there position will be closed out minutes later when they go in and buy your shares. To avoid doubling up on trade volume and distorting the picture, only the sale into the market (consolidated tape) is recorded and not the second leg which was the sale transaction between seller and market maker.
So, this is why the short sale volume is high but also why the FTD’s and bi-Monthly short interest reports are not showing any indications of this volume. The short isn’t really a short it is the execution of a long sale by a market maker. The key language in the FINRA notice is this:
Quote:
--------------------------------------------------------------------------------
The Daily Short Sale Volume File will provide daily access to the aggregate volume of short sales in NMS Stocks and OTC Equity Securities reported to a consolidated tape and traded over-the-counter during regular trading hours on each trading day.
Small Biotech plays are the place to be... Large drug/biotech companies are looking at every prospect for a buyout or partnership. CTIX valuation compared to Juno, ISIS Pharma and so on is extremely cheap... The smart money will find CTIX and an uplising will draw the large players here. GLTY
Classic buy the rumor, sell the news... The B news was almost predicted to the exact day on this board. Need another wave of new buyers to enter now...
The Nasdaq Capital Market does require holding a bid price of 4 for 90 days before applying. See below... If CTIX qualified for the closing price alternative, they surely would have up-listed by now. A close of 2 or 3 is needed for that standard. This is not being negative, just presenting facts since some believe a 4 dollar PPS automatically assumes they can up-list... GLTY
** To qualify under the closing price alternative, a company must have: (i) average annual revenues of $6 million for three years, or (ii) net tangible assets of $5 million, or (iii) net tangible assets of $2 million and a 3 year operating history, in addition to satisfying the other financial and liquidity requirements listed above
* Currently traded companies qualifying solely under the Market Value Standard must meet the $50 million Market Value of Listed Securities and the applicable bid price requirement for 90 consecutive trading days before applying
LR, There might be an issue of CTIX qualifying under the closing price alternative ** See below Thereby, they'll need to meet the 4 dollar bid requirement for 90 conservative days. The question is why was there an application submitted when they never met qualifications? The debate back then was about needing BODs, but it appears they may need a sustained bid price of 4. That's a tougher task than trading 4 or above a few days. See page 9... Some posts are suggesting once they reach 4 they can up-list..
https://listingcenter.nasdaq.com/assets/initialguide.pdf
* Currently traded companies qualifying solely under the Market Value Standard must meet the $50 million Market Value of Listed Securities and the applicable bid price "which is 4 dollars" for 90 consecutive trading days before applying.
** To qualify under the closing price alternative, a company must have: (i) average annual revenues of $6 million for three years, or (ii) net tangible assets of $5 million, or (iii) net tangible assets of $2 million and a 3 year operating history, in addition to satisfying the other financial and liquidity requirements listed above
https://listingcenter.nasdaq.com/assets/initialguide.pdf
The minimum PPS standard to up-list is 3. There was some discussion of 2 for Market Value of Listed Securities Standard* ... See page 9 Nasdaq Capital Market... GLTY
https://listingcenter.nasdaq.com/assets/initialguide.pdf
I knew we'd have a few posts mentioning flippers and short sellers. a 10 percent gain is not good enough for some people. It's a stock market, meaning buying/selling...
The reason the PPS is jumping is not the approval, but the findings that would allow such. There's a review board that will approve if CTIX meets requirement. Other factors involved (rally) is the continued biotech bull-market (mergers/buyouts) and the potential P/B news. This all spells out a higher PPS.
http://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions/HowtoapplyforOrphanProductDesignation/default.htm
200 Per/Share? You'd be thrown off Shark Tank. That's a 24 billion valuation, which rises as shares are diluted... A 7 billion valuation (Receptos Deal) on CTIX today is worth 58 per/share. I see CTIX selling out when the time is right. Let someone else do the hard work after the Phase 3 trials. GLTY
Nice read: Partnerships Rather Than Buyouts May Become Big Pharma's Choice In Collaborating With Biotechs...
http://www.forbes.com/sites/genemarcial/2015/07/12/partnerships-rather-than-buyouts-may-become-big-pharmas-choice-in-collaborating-with-biotechs/?utm_campaign=yahootix&partner=yahootix
Franklin's New Additions link from the Nasdaq. CTIX page 2...
Good find F1ash.... Interesting, they spent more on CTIX than Comcast...
http://www.nasdaq.com/quotes/institutional-portfolio/franklin-street-advisors-inc-nc-63421/new?page=2
Nice Read.. House expected to pass legislation to speed drug development...
http://www.bloomberg.com/news/articles/2015-07-09/house-considers-speeding-drug-development-as-opposition-mounts
Drano, It's all good, most posts here are speculation good/bad based on previous history. The insiders probably read this forum, but not sure they post? GLTY
JTORENCE, Gold, CTIX and a few REITS did OK today. US market is holding it's own considering the China/Greece collapse. GLTY
Drano, Sort of like your mysterious knowledge of trading CTIX... Please keep us informed on how well you trade this stock? I guess you failed to predict today's climb? LOL
He just got back... I said earlier, on pace for 200k shares trading with a 2.50 plus bounce possible. Maybe, B info leaked?
Crazy, Leo picked a good time to go on vacation for a month... Greece, China, NYSE "possible cyber attack" and so on...
Volume is better today, on pace for 200K... See if 2.50 plus can be had...
Lets hope, high risk assets (CTIX) haven't burned and crashed by the time Leo comes back from vacation? China is more of a concern then Greece now... Hopefully, Aspire and Aruda don't need to liquidate more shares?
Pending status since early Feb... There has to be a "time period" before they're application is removed from pending? Also, Leo never specified what the PPS requirement is? 3 or 4 is a big difference...
Not much happening in CTIX world these days. The last PR was an up-listing denial due to a low PPS. A good time to lay-off employees for the summer.
Loanranger, An up-listing would have required an annual SH meeting, now Leo is off-the-hook. I don't recall CTIX ever having a meeting?
***In case it's not obvious from that comment, the next 10-K (or a proxy statement ahead of a shareholder meeting) SHOULD show Aruda's holding if it's still over 5% of the outstanding on the "as of" date.
Imagine if Greece had an effect on CTIX? Down 3.64 percent on it's own behalf...
What shuffle? The pink-sheet followers of tiny biotech? LOL
Next PR was already telegraphed by Leo... Corporate update number 15... Sometime after B news... Yawn...